Loss on Transfer of Nonfinancial Assets

12 Months Ended

Dec. 31, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Loss on Transfer of Nonfinancial Assets

ON SALE OF NONFINANCIAL ASSETS

During the year ended December 31, 2022, a third party, who had previously acquired rights to certain intellectual

property from the Company, terminated the arrangement and transferred these rights back to the Company. Also during the year ended December 31, 2022, the Company transferred these rights to another third party in return for $0.5 million. The

Company has no continuing involvement in any ongoing research and development activities associated with the intellectual

property. The Company concluded that these third parties are "non-customers" as the underlying intellectual property

transferred to and from these third parties supports potential drug candidates that are not aligned with the Company's strategic

focus and, therefore, are not an output of the Company's ordinary activities. Accordingly, the Company accounted for the sale

of the intellectual property as the sale of a non-financial asset under ASC Topic 610-20, Gains and Losses from the

Derecognition of Nonfinancial Assets ("ASC 610-20"), and included the gain in gain on sale of non-financial asset for the year ended December 31, 2022.